On 27 September, the Good Clinical Trials Collaborative submitted its commentary on the draft Good Clinical Practice (GCP) E6R(3) guidelines to the European Medicines Agency (EMA), in response to the public consultation launched by the International Council of Harmonisation of Technical Requirements for Pharmaceuticals for Human…
In August, the Collaborative and four major clinical trials networks unveiled a strategic collaboration aimed at bolstering clinical trials research in low- and middle-income countries. In a new article in Clinical Leader, Nick Medhurst delves into how Good Trials Prism can play a pivotal role…
The Good Clinical Trials Collaborative has submitted feedback on the World Health Organization’s draft clinical trials best practice guidance, in response to its public consultation launched in July 2023.
The Good Clinical Trials Collaborative has submitted commentaries to national regulatory authorities, responding to the public consultation launched by the International Council of Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) in May 2023.
Highlights of this edition include World Health Organization’s public consultation of its draft clinical trials guidance and Professor Sir Martin Landray's participation in NIH Pragmatic Trials Collaboratory's webinar on Friday, 18 August, discussing International Council of Harmonisation’s updated guidelines for Good Clinical Practice.
Four major clinical trial networks based in low resource settings and the GCTC coordinating center at Protas, have formed Good Trials Prism - an exciting partnership to enhance clinical research in low resource settings.
In this instalment of #GoodTrialsGrapevine, Dr. Mo Yin, Deputy Director of ADVANCE-ID, a leading clinical trials network based in Southeast Asia, shares her valuable insights into the benefits of collaboration, including boosting the quality and efficiency of clinical research in the diverse region of Asia.